A radioimmunoassay for glucagon has been used to study the regulation of the plasma glucagon concentration in sheep. The mean plasma glucagon concentra· tion after an overnight fast was 0·20 ng/ml in crossbred sheep and 0 ·12 ng/ml in Merinos. During a more prolonged fast plasma glucagon concentrations declined.
A radioimmunoassay for glucagon has been used to study the regulation of the plasma glucagon concentration in sheep. The mean plasma glucagon concentra· tion after an overnight fast was 0·20 ng/ml in crossbred sheep and 0 ·12 ng/ml in Merinos. During a more prolonged fast plasma glucagon concentrations declined.
Following the feeding of 800 g lucerne chaff: oats (1: 1), plasma concentra· tions of both glucagon and insulin increased from 0·19 ng/ml and 16·3 microunits/ml respectively to maximum levels of 0·41 ng/ml and 51 microunits/ml 2 hr later and remained high for 2 hr. Glucagon and insulin concentrations then declined steadily till the next feeding time. In contrast plasma growth hormone concentrations declined to a minimum 2-4 hr after feeding and then increased slowly towards pre-feeding values; they did not increase further during prolonged fasting. These changes were associated with increased plasma volatile fatty acids (VFA) levels during the first 8 hr after feeding but there were no increases in plasma glucose or <x-amino nitrogen concentrations during this period.
Intravenous injection of 0·25 mmole/kg body weight of propionate, butyrate, or valerate was followed by very large increases in plasma glucagon, insulin, and glucose concentrations. These effects were much reduced when the same amounts of propionate or butyrate were administered via the abomasum and were absent altogether if they were given into the rumen. Continuous infusion of a mixture of VFA into the rumen for 2 hr, which increased plasma VFA concentration to a value similar to that observed after feeding, also failed to increase glucagon or insulin concentrations. The physiological role of the VF A as stimulators of glucagon or insulin secretion in ruminants therefore remains questionable.
Intravenous infusion of glucose (0·5 g/min) appeared to reduce glucagon concentrations, but infusion of adrenaline, which also increased plasma glucose, increased glucagon concentrations. Isoprenaline had no clear effect on glucagon levels.
I. INTRODUCTION
The volatile fatty acids (VFA), except for acetate, are potent stimulators of insulin release in sheep when given parenterally Horino et al. 1968) . Despite this action, these acids are also potent hyperglycaemic agents in this species (Potter 1952; Phillips and Black 1966; Ash, Pennington, and Reid 1964) . It has been shown that the hyperglycaemic response is due to hepatic glycogenolysis (Phillips, Black, and Moller 1965) and is abolished by pancreatectomy (Phillips et al. 1969; Jones et al. 1970) . It is, therefore, very likely that the VFA, like several other compounds such as pancreozymin (Unger et al. 1967 ) and amino acids (Fajans et al. 1967) , may stimulate the secretion of glucagon as well as insulin from the pancreas. Because of the mode of digestion in ruminants and the dependence of these species on gluconeogenesis for the major part of their glucose requirements (Katz and Bergman 1969) , sthnulatory e:lfects of the VFA (the principal end-products of carbohydrate digestion) on the release of both glucagon and insulin might be of considerable importance in homeostatic regulation in these species.
This paper reports studies carried out to examine plasma glucagon concentrations in sheep and their relation to plasma levels of insulin and growth hormone.
The effects of feeding and hyperglycaemia have been determined and the possibility that the post-prandial rise in VFA production is involved in regulating glucagon secretion has been examined.
II. MATERIALS AND METHODS

(a) Animals
Six adult Border Leicester x Merino wethers of body weight 60·0±3·8kg (mean±S.E.) and eight Merino wethers of body weight 44· 3 ± 1 . 1 kg were maintained in individual pens and fed 800 g lucerne chaff and oat grain (1: 1) daily. Each Merino wether was fitted with cannulae in the rumen and abomasum.
(b) Experimental
Biood samples were obtained by jugular venipuncture using heparinized syringes and with minimal disturbance to the animals. The samples were kept on ice until centrifuged within 15 min of collection. To prevent breakdown of glucagon during storage 500 Kallikrein Inacti· vator Units (KIU) Trasylol (FBA Pharmaceuticals Pty. Ltd.) per millilitre was added to plasma for glUcagon assay immediately after separation (Unger et al. 1967; Heding 1971) . In a comparison of '10 plasma samples stored with or without added Trasylol, glucagon concentrations in unprotected samples were only 59·6±3·9% of these in samples protected by addition of 500 KIU Trasylol per millilitre. Plasma was stored at -20°C until required for assay.
Intravenous injections were given by hypodermic syringe into the left jugular vein and were generally completed within 2 min. Intravenous infusions were given using a peristaltic pump via a polyethylene catheter placed in the left jugular vein at least one day before the experiment.
Rapid addition of VFA to the rumen or abomasum was done by mixing the fatty acid solution in 200 ml of rumen liquor obtained from another similar sheep. Continuous infusions of VF A into the rumen were given at a rate of i ml/min via a polyethylene catheter passing through the bung fitted into the rumen cannula. The infusion was started after adding a priming dose of 90 ml of the VFA solution mixed with 500 ml rumen liquor.
(c) Infusion Solutions
For intravenous injection 2· OM solutions of the VF A were prepared and adjusted to pH 7·4 by addition of NaOH. For intravenous infusion a 2 mM solution of propionic acid was made and adjusted to pH 7·4 with NaOH. Before use all VFA solutions were passed through a membrane filter (Millipore). For intraruminal or abomasal injection 2· OM solutions of the VFA were prepared and adjusted to pH 5·5 or 2·4 respectively. For intraruminal infusion of a VF A mixture, a solution was prepared containing 3· OM acetate, I· OM propionate, and O· 5M butyrate, and adjusted to pH 5·5.
Adrenaline (adrenaline bitartrate, British Drug I:Iouses, Ltd.) and isoprenaline (isopropyl noradrenaline, Sigma) were made up as 25 P.M solutions in 0'9% saline containing 0'03% ascorbic acid as a preservative.
Glucose for infusion was obtained as a sterile 50% solution in water (Farmer Hill, Sydney).
(d) Analytical
The plasma concentration of glucose, ~as determined by the glucose oxidase method of Huggett and Nixon (1957) , and that of short-chain volatile fatty acids by the steam distillation method of McClendon (1944) . Plasma <x-amino nitrogen concentrations were'determined by the method of Frame, Russell, and Wilhelmi (1943) . Plasma concentrations of insulin and growth hormone (GH) were measured by radioimmunoassay using talc to separate antibody-bound from free labelled hormone as described previously (Wallace and Bassett 1970; Bassett and Thorburn 1971) . The glucagon concentration in plasma was determined by a similar radioimmunoassay method. The glucagon antiserum used was from the late J. D. YOWlg, The Garvan Institute, St. Vincent's Hospital, Sydney. This antiserum showed no cross-reaction with an acid-ethanol extract of sheep small intestine at a concentration (100 p.g/ml) which caused complete displacement of label from another nonspecific anti-glucagon serum. It also showed no cross-reaction with an extract of pig small intestine (Kraegen and Young, personal communication). The plasma immunoreactive glucagon concentrations measured are therefore considered to be pancreatic glucagon. 125I-Iabelled glucagon was prepared by the method of Greenwood, Hunter and Glover (1963) using 25 p.g beef-pork glucagon (Batch 258-234B-167-1, Eli Lilly and Co., Indianapolis, U.S.A.) and 2 mCi sodium [125I]iodide (Radiochemical Centre, Amersham, England). After iodination the labelled glucagon was separated from salt todide and purified by gel filtration on a 15 by 1 cm column of Sephadex G25 presaturated with a 0·25% albumin: phosphate buffer (pH 8·0). The glucagon peak was diluted immediately to a concentration of approximately 10 ng/ml in buffer containing 1000 KIU Trasylol/ml, and frozen in 1 ml portions till required. In the assay for glucagon, O· 25 ml plasma or glucagon was added to 1 ml glucagon antiserum (1 : 50,000) diluted in 40 mM phosphate buffer (pH 8·0) containing 0·25% bovine albumin (Armour), 1000 KIU/ml Trasylol, and 10% aged ovine plasma. This mixture was incubated at 4°C for 24 hr before adding 100 pg 125I-Iabelled glucagon in 0·1 ml phosphate buffer. Incubation was then continued a further 48 hr at 4°C. To equalize the amount of plasma in each tube before adding talc, the appropriate amount of ovine plasma was added to standards and to plasma samples when dilution was necessary. One millilitre of a talc slurry (75 mg/ml) was then added to separate antibody-bound hormone from free hormone. The tubes were centrifuged and the talc pellet washed as in the assays for growth hormone (Wallace and Bassett 1970) .
Trasylol was added to prevent destruction of the labelled glucagon during incubation. Aged ovine plasma, with little glucagon in it, was added to the assay buffer since it was found, from a comparison of standards diluted in buffer or in plasma, that anomalously low amounts of labelled glucagon appeared to bind to the glucagon antiserum in the complete absence of plasma during incubation, even though plasma was added before adding talc. Using pairs of duplicate observations the coefficient of variation of the method was 25% for values less than 0·2 ng/ml, 12· 5% for values in the range O· 2-0·5 ng/ml, and 9·5% for values of 0·5--1·0 ng/ml.
(e) Oalculations
Since the absolute concentrations in sheep plasma of several hormones do not form samples of a normal distribution but their logarithms do (Bassett and Thorburn 1971) , concentrations of insulin, growth hormone, and glucagon were converted to common logarithms before calculation of means. The means reported are therefore geometric means. Statistical significance was assessed on the transformed values by use of a conventional t-test.
III. RESULTS
(a) Plasma Glucagon Concentrations in Sheep Fasted Overnight
After an overnight fast the mean concentration of glucagon in jugular vein plasma from the crossbred sheep was 0'20ng/ml (meanloglO±S.E., -0·69±0·07) and in the Merino wethers the concentration was 0·12 ng/ml (-O·92±0·05). The concentrations seemed to be characteristic of individual animals and there was little variation from day to day. At this time the mean plasma insulin concentration for all sheep was 13 microunits/ml.
(b) Effect of Feeding and Prolonged Fasting on Plasma Glucagon Concentrations
There were significant increases (P < 0·01) in the mean plasma concentration of glucagon 2-4 hr after feeding when the six crossbred wethers were offered 800 g
,.
\1' / r }----t__ of a mixed lucerne chaff: oat grain diet (Fig. I ). There were also similar changes in insulin but, in contrast, plasma GR concentrations declined to a nadir 2-4 hr after feeding. When the relationship between plasma glucose and glucagon levels in samples collected during the first 8 hr after feeding was examined, it was found that therewasahighlysignificantinversecorrelation(r = -0·704; n = 36; P < 0·001).
There was also a less striking but statistically significant inverse correlation (r = -0·342; P < 0·05) between plasma a-amino nitrogen and glucagon concentrations. Increased plasma insulin concentrations were associated with decreased plasma levels of glucose (r = -0·423; P < 0·001) and free amino acids (r = -0·456; P < 0'0l) during the first 8 hr after feeding. Also, increases in glucagon and insulin concentrations occurred at the same time as a marked increase in plasma VF A concentration. However, peak VFA concentrations occurred after the peaks in glucagon and insulin concentrations were reached. Plasma concentrations of glucagon were correlated with those of VFA (r = 0'420, P < 0·01) but the correlation was less than that with plasma glucose. ;l'
• __ -. During a subsequent prolonged fast (4 days) concentrations in plasma of both glucagon and insulin declined steadily (Fig. 1) , whereas that of GH returned to the pre-feeding level during the first 24 hr and then stabilized at this level. Even though plasma glucose concentrations declined somewhat, there was no increase in the plasma glucagon concentration during this period.
(c) Effect of Glucose or Oatecholamine Infusion on Plasma Glucagon Ooncentrations
Since hyperglycaemia has been shown in other species to suppress glucagon secretion, the blood glucose concentration was elevated in a number of ways (Fig. 2) . Intravenous infusion of glucose at a rate of 0·5 g/min into three crossbred sheep increased their plasma glucose to 230 mg/l00 ml after 30 min infusion and to 430 mg/100 ml by the end of the 2 hr infusion. However, this caused only a small decrease in their plasma glucagon level, from the pre-infusion concentration of 0 ·28 ng/ml to 0·21 ng/ml after 90 min infusion. . , , ,
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' . Infusion of a f3-adrenergic stimulator, isoprenaline (0·025 fhmole/min for 2 hr), into two crossbred sheep increased their plasma glucose concentration to 91 mg/100 rnl and their insulin concentration to 70 microunits/ml, but had no effect on the concentration of glucagon. On the other hand intravenous infusion of an a-adrenergic stimulator, adrenaline (0·025 fhmole/min), for 2 hr into two other crossbred sheep appeared to cause a transient increase in their plasma glucagon concentration from 0 . 24 to 0·33 ng/ml in the first 30 min of infusion, even though the glucose concentration increased from 58·5 to 107 mg per 100 rnl during this period; after this, however, glucagon declined.
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(d) Effects of Propionate, Butyrate, or Valerate on Plasma Glucagon Ooncentration
Intravenous injection oflarge amounts (2·5 mmoles/kg) of propionate, butyrate, or valerate was followed by very rapid and large increases in the plasma glucagon concentration and also by very large increases in the plasma insulin and glucose concentrations (Fig. 3) . The increases in glucagon and insulin were more prolonged after valerate injection than after butyrate or propionate administration. Continuous intravenous infusion of a much smaller amount of propionate (2 mmolesjmin) into a single crossbred sheep was also followed by rapid increases in plasma concentrations of both glucagon and insulin, but despite continued infusion of propionate for 60 min plasma concentrations of insulin and glucagon declined towards the normal range after the first 15 min of infusion (Fig. 4) . Since the VF A normally enter the circulation from the digestive tract through the portal vein and may therefore be extensively metabolized in the liver, the same amounts of propionate and buytrate as given intravenously were also given by rapid administration into either the rumen or abomasum. Administration by either of these routes greatly diminished all the effects of both these acids. Mter injection into the rumen there were no statistically significant alterations in plasma glucagon or glucose concentrations, but butyrate did increase insulin concentration slightly (Fig. 5 ).
After injection of propionate or butyrate into the abomasum there were significant increases in plasma glucagon, insulin, and glucose levels, but these were far smaller than those seen following intravenous injection.
In a further attempt to assess the influence of the gastrointestinal tract and the liver on the ability of the VF A to stimulate secretion of insulin and glucagon, a mixture of VFA, similar in amount and molar proportions (acetate 60: propionate 20: butyrate 10) to the amounts produced in the rumen after feeding (Weston and Rogan 1968), was infused for 2 hr into the rumen of four sheep. Even though this infusion significantly increased the plasma VFA to a concentration similar to that after feeding, it had no effect on the plasma glucagon concentration and only a marginal effect on the plasma insulin concentration which was not in any way comparable to that seen after feeding ( Table 1) . (2·183  (2·112  (2 ·152  (2·149  (2·135  ±0·047) ±0·048) ±0·053) ±0·072) ±0'038) ±0'033) Glucosej: 63·0 64·0 65·0 66·0 68·0 70·0 (mg per 100 ml) ± 2·5 ± 2·2 ± 3·8 ± 3·9 ± 3·9 ± 3·2 VFAj: 0·28 0'66* 0'72*** 0'91*** 0·72 0·61** (mmole/l) ± 0·03 ± 0·10 ± 0·05 ± 0·08 ± 0·08 ± 0·07
* Differences significant at P < 0·05; ** P < 0·0l; *** P < 0·001.
t Values given in first lines are geometric means, whilst those in parenthesis are IOglO values ± standard error. j: Mean±standard error.
IV. DISCUSSION
Since the antiserum used in the assay for glucagon showed no cross-reaction with extracts of sheep intestinal tissue the assay is probably specific for pancreatic glucagon and the results observed can be regarded as reflecting changes in glucagon release from the pancreas. The plasma glucagon concentrations observed in sheep after overnight fasting are similar to those observed in other species using specific antisera (Muller et al. 1970; Reding 1971) and are lower than values in pregnant ewes determined by a non-specific assay method (Alexander et al. 1971) . The changes seen following hyperglycaemia or adrenaline administration are also consistent with those reported by others Leclercq-Meyer, Brisson, and Malaisse 1971) .
Feeding was followed by significant increases in the plasma concentrations of both glucagon and insulin (Fig. I) , even though there were decreases rather than increases in the plasma concentrations of both glucose and <x-amino nitrogen. The GH level also declined following feeding, which was consistent with earlier observations (Wallace and Bassett 1970) . Since hypoglycaemia is a known stimulus to glucagon release (Buchanan et al. 1969; Ohneda et al. 1969 ) the small decrease in plasma glucose following feeding, which showed a striking inverse correlation with the change in plasma glucagon, might seem sufficient explanation for the increased glucagon release. However, this leaves entirely unexplained the marked increase in insulin or the decrease in GH which also occurred, and which clearly cannot be explained by the alterations in glycaemia. It seems far more likely that the rises in Iboth insulin and glucagon are associated with a common stimulus, and the decreased iplasma glucose and <x-amino nitrogen concentrations probably reflect a dominance of the anabolic effects of insulin in this situation. The decrease in GH is probably also related to the increase in insulin since it has been observed in earlier work (Bassett, Weston, and Hogan 1971) that insulin and GH levels are inversely correlated, but the mechanism involved is not known.
Amino acids stimulate the release of both insulin and glucagon (Ohneda et al. 1968; Unger et al. 1969) , but, as their plasma concentrations tend to decline rather than increase following feeding, they seem unlikely to explain the observed increases in insulin and glucagon secretion. This leaves either the gastrointestinal hormone pancreozymin (Unger et al. 1967) or the fatty acids propionate and butyrate as possible stimulators of insulin and glucagon release. Earlier observations have indicated that the plasma insulin level is positively related to the digestion of amino acids in the small intestine Faichney and Weston 1971) and pancreozymin has been shown to stimulate insulin release in ruminants (Baile, Glick and Mayer 1969) . There is also a striking similarity between the changes in plasma glucagon and insulin concentrations after feeding, reported here, and the pattern of changes in abomasal secretion and flow of ingesta from the abomasum to the duodenum reported by Hill (1961) . However, while this is strongly suggestive of a causal link between gastrointestinal hormone release after feeding and the secretion of glucagon and insulin, further information about changes in secretion of the gastroinsestinal hormones, especially pancreozymin, is required for their role to be assessed. The increases in plasma VF A concentration following feeding also occur at the same time as the increases in glucagon and insulin, so the VF A should be considered as potential physiological stimuli to insulin and glucagon release in this situation. Intravenous administration of propIonate, butyrate, or valerate caused striking increases in the plasma glucagon concentration of sheep, which confirms the conclusions of earlier workers that the hyperglycaemic action of these acids is mediated by the <x-cells of the pancreas (Manns, Boda, and Willes 1967; Phillips et al. 1969) . The greater potency of valerate than butyrate or propionate at stimulating glucagon secretion is consistent with their ranking as stimulators of hyperglycaemia in the sheep (Phillips et al. 1969) , though there was little difference between them in their effect on plasma glucose in the present study. It has been speculated that the stimulation of insulin release by the VF A could be secondary to a stimulation of glucagon release . However, in the present studies the rapid increases in insulin and glucagon concentration appeared to occur almost simultaneously and it is not possible to determine whether changes in glucagon preceded those in insulin. The magnitude of the changes in both is so large that.it seems more likely that the VF A directly influence the secretion of both insulin and glucagon. These acids are therefore potent stimuli to the release of both the major hormones secreted by the islets of Langerhans in sheep. Howe¥er, the present experiments shed no light on the mechanism by which this secretion is stimulated. This effect of the VFA is totally at ¥ariance with the suppressi¥e effect of octanoate on the secretion of glucagon by the a-cells of guinea-pig islets of Langerhans (Edwards and Taylor 1970) or the effects of changes in plasma free-fatty-acid concentrations on glucagon release in dogs (Luyckx and Lefebwe 1970), but the reason for this difference is not known. It is pertinent, howe¥er, to note that the stimulatory effect of the VFA on insulin release is confined to ruminants (Horino et al. 1968) .
While some of the VF A are clearly potent stimulators of both glucagon and insulin release under appropriate conditions, their physiological importance as regulators of glucagon or insulin release in ruminants remains uncertain. The present experiments pro¥ide no conclusi¥e eTIdence in fa¥our of their ha¥ing a significant role in determining hormone secretion after feeding in sheep. It should be pointed out that acetate probably accounts for 95% or more of the plasma VFA concentration, since ¥irtually all the propionate and butyrate entering the portal ¥ein is remo¥ed by the li¥er in a single passage, and arterial plasma propionate and butyrate concentrations remain extremely low e¥en in fed sheep (Bergman and Wolff 1971) . The failure of the VF A to stimulate glucagon or insulin release when gi¥en TIa the rumen, either as a single injection or as an infusion which resulted in -changes in plasma VFA similar to those after feeding, are consistent with extensi¥e metabolism of propionate and butyrate by the tissues of the gut and li¥er and, like the studies of Stern, Baile, and Mayer (1970) , gi¥e no support to the belief that either propionate or butyrate is physiologically significant as a stimulator of either insulin or glucagon release. In TIew of the close simulation of the post-prandial situation in these experiments, the physiological significance of propionate and butyrate as stimulators of glucagon and insulin release in ruminants must remain ¥ery questionable.
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